Erivedge: first targeted therapy for basal cell carcinomaNew drug indicated in adults for the treatment of histologically confirmed metastatic basal cell carcinoma or locally advanced basal cell carcinoma that is inappropriate for surgery or radiotherapy CCBs linked with breast cancer Fitness in midlife predicts cancer incidence and survival in men Even a small improvement in exercise capacity makes a difference Radiation safe in lymph node-positive breast cancer Recurrence rates similar, swelling less common than with surgery Night shifts a breast cancer risk New cancer drugs release the brakes on the immune system Early trials of immunotherapy mark ‘new chapter’ in oncology Guidelines for prevention of acute antineoplastic-induced nausea and vomiting in children Pediatric Oncology Group of Ontario spearheads development of guidelines for the prevention of acute antineoplastic-induced nausea and vomiting in children. CUA: Prostate inflammation cuts cancer risk Finding has implications for biopsy followup CUA: Testosterone level should guide androgen deprivation therapy Analysis shows importance of reaching low values CUA: A new way to zap the prostate—MRI-guided laser ablation Outpatient procedure has low morbidity but high failure rate First Previous 48 49 50 51 52 Next Last
